Contribution of a Single Islet Transplant Program to Basic Researchers in North America, Europe, and Asia through Distributing Human Islets
Abstract
(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)
Contribution of a Single Islet Transplant Program to Basic Researchers in North America, Europe, and Asia through Distributing Human Isletsby
Tatsuya Kin
,
Doug O'Gorman
,
Wendy Zhai
,
Jennifer Moriarty
,
Kyle Park
,
Advaita Ganguly
,
Shawn Rosichuk
and
AM James Shapiro
Abstract There has been a steady expansion in islet isolation and transplantation activity worldwide. In addition to preparing human islets for transplantation, we have been providing human islets to basic researchers. The aim of this study was to review the activity of distribution of human islets to basic researchers in North America, Europe, and Asia, and [...] |
Thrombotic Microangiopathy in Solid Organ Transplantationby
Sravanthi Nandavaram
,
Hannah Twist
,
Rickey Evans
,
Sravanthi Paluri
,
Ana Castellanos
and
Andres Pelaez
Abstract Thrombotic Microangiopathy (TMA) is a syndrome characterized by microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. The presence of schistocytes on peripheral smear, a negative Coombs test, elevated lactate dehydrogenase, increased reticulocyte count and low haptoglobin are often the clues for MAHA. The microvascular process often targets [...] |
Management of Steatosis in Living Donors: Where Do We Stand?Abstract With the progressive rise in rates of liver transplantation, stagnant donor pool, and social factors, living donor liver transplantation (LDLT) forms the majority of liver transplantations performed in Asian countries. As the global prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing, around 17-25% of all the prospective donors [...] |
Airway Complications after Lung Transplantationby
Syed Nazeer Mahmood
and
Amit Mahajan
Abstract Lung transplantation in patients with end stage lung disease can improve survival and quality of life. Airway complication incidence varies between 2-33%, but the true incidence is difficult to determine due to a lack of validated classification systems. There are many risk factors for post lung transplant airway complications, the most common being [...] |
Calculated Human Leucocyte Antigens Evolutionary Divergence (cHED)by
Bruno A Lima
Abstract Human Leucocyte Antigens (HLA) constitute a highly polymorphic set of genes pivotal to the immune response. The HLA heterozygous advantage hypothesis assumes that heterozygous individuals at the HLA level have a wider range of peptides for T cell recognition than homozygous individuals. Consequently, they possess an enhanced capacity to trigger a target [...] |
Chronic Lung Allograft Dysfunction, a Review in 2023Abstract Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation [1]. CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable etiology as infection or acute rejection. Multiple risk factors [...] |
Evaluation of Total Parenteral Nutrition in the Autologous Transplantation Setting in Patients with AML: A Retrospective Exploratory Analysisby
Sarah Willi
,
Ulrike Bacher
,
Marie Noelle Kronig
,
Michael Daskalakis
,
Lia Bally
and
Thomas Pabst
Abstract Malnutrition remains a clinical challenge in AML patients undergoing autologous hematopoietic stem cell transplantation (ASCT), leading to physical deconditioning and prolonged hospitalization. Prospective data are mainly lacking to identify those patients who may particularly benefit from parenteral nutrition in this setting. This observational, non [...] |
Acknowledgement to Reviewers of OBM Transplantation in 2023Abstract The editors of OBM Transplantation would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2023. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal’s editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual public [...] |
Immune-Suppression Modulation in Solid Organ Transplant Recipients Admitted for COVID-19by
Francesco Peracchi
,
Giovanna Travi
,
Marco Merli
,
Roberto Rossotti
,
Fulvio Crippa
and
Massimo Puoti
Abstract SARS-CoV-2 infection has significantly impacted solid organ transplant (SOT) recipients, who are at high risk of disease and worse outcomes. Moreover, therapeutic management in this population is not precise yet. Our study aimed to evaluate the overall survival of SOT recipients and predictive factors for mortality. We also aimed to assess the impact [...] |
Lung Donor Selection and Management: An Updated Reviewby
Shefali Mody
,
Soham Nadkarni
,
Shreyash Vats
,
Akshay Kumar
,
Sravanthi Nandavaram
and
Suresh Keshavamurthy
Abstract The shortage of donor lungs for transplantation is a major challenge, resulting in longer waitlist times for patients with a higher risk of waitlist mortality. It is crucial to continue promoting awareness about organ donation through legislation, public campaigns, and health care provider education. Only a small number of cadaveric donors meet the [...] |
Acute Rejection of the Lung Allograft: Phenotypes and ManagementAbstract Treatment options for end stage lung diseases are limited to stabilizing lung failure, decreasing disease progression, and symptom management, but significant reversal of lost lung function is often not possible. For well selected patients, lung transplantation may be a viable option to improve both longevity and quality of life. Though outcomes for [...] |
HLA Typing and Donor-Specific Antibody Screening in Kidney Transplantation: Bridging the Past to the Futureby
Mostafa Mohammed
,
Esmat Al Sharkawy
,
Amel M. Kamal Eldin
,
Emad Allam
,
Manal M. Saber
,
Anthony Nassar
,
Nour Younis
,
Christa Deban
,
Ahmad Jaser
,
Indira Guleria
,
Basset El Essawy
,
Anil Chandraker
,
Mahmoud Nasr
and
Jamil Azzi
Abstract Human leukocyte antigens (HLA) are unique proteins expressed on the surface of human cells, playing a pivotal role in the immune system, particularly in the contexts of infection, cancer, and transplantation. The widespread adoption of HLA typing methods has become an essential component in assessing donor-recipient compatibility, a crucial limiting [...] |
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Seriesby
Biagio Pinchera
,
Rosa Carrano
,
Emilia Trucillo
,
Alessia D'Agostino
,
Alessia Sardanelli
,
Simona Mercinelli
,
Fabrizio Salemi
,
Amerigo Piccione
,
Elisa Schettino
,
Paolo Romano
,
Gianluca Rompianesi
,
Roberto Ivan Troisi
and
Ivan Gentile
Abstract The rising prevalence of MDR pathogens has a significant impact on the recipients' outcome, as this increases the risk of graft complications and makes the management of the peri-transplant phase more difficult. Among the different MDR germs, Methicillin-resistant Staphylococcus aureus (MRSA) represents one of the most frequently isolated pathogens [...] |
Utility of MEST and MEST-C Scoring in IgA Nephropathy in Kidney Transplantation: A Mini ReviewAbstract IgAN is a major cause of end-stage kidney disease (ESKD) leading to kidney transplantation in a significant proportion of patients. However, its recurrence in transplanted kidneys can lead to graft loss. The rate of graft loss attributable to IgAN after transplantation is variably reported in different retrospective cohorts. Previous reports describe [...] |
Multimodal Pain Management of Liver Transplantation: What Is New?Abstract Liver transplantation (LT) is a life-saving treatment representing the only viable option for patients suffering from end-stage liver disease (ESLD) or acute liver failure. Patients who undergo LT require a multidisciplinary approach to postoperative pain management. However, pain management in this context is often inadequately explored. Limited option [...] |
Lung Transplantation: Selection of CandidatesAbstract Lung transplantation is a last-resort treatment option for patients with end stage lung disease. The procedure is being performed more frequently and scientific advances continue to be made, but the median post-transplant survival is far shorter than other solid organ transplant recipients. Candidate selection is a resource intensive process that attemp [...] |
A Urinary Proteomics Approach to Predict Treatment Response in Acute Antibody-Mediated Rejectionby
Somaye-Sadat Heidari
,
Nooshin Dalili
,
Shiva Samavat
,
Shiva Kalantari
,
Leonard Foster
,
Kyung-Mee Moon
and
Mohsen Nafar
Abstract Acute antibody-mediated rejection (AMR) is a severe complication affecting kidney allografts' long-term survival. Timely detection and appropriate treatment of AMR are crucial for improving graft outcomes. This study aimed to discover non-invasive urinary biomarkers that can predict the response to therapy in patients with AMR. Materials and Methods: [...] |
Oral Versus Intravenous Anti-CMV Preemptive Strategies in Allogeneic Stem Cell Transplant Patients with CMV Reactivation: Experience from the National Center of Bone Marrow Transplantation, Tunis, Tunisiaby
Rimmel Yosra Kanoun
,
Nour Ben Abdeljelil
,
Roua Hsasna
,
Rabeb Jaied
,
Sabrine Mekni
,
Siwar Frigui
,
Lamia Torjemane
,
Dorra Belloumi
,
Ines Turki
,
Rihab Ouerghi
,
Insaf Ben yaiche
,
Wafa Achour
,
Saloua Ladeb
and
Tarek Ben Othman
Abstract Cytomegalovirus (CMV) infection is a common and severe complication following allogeneic stem cell transplantation (ASCT) and requires effective preemptive antiviral therapy. Both oral and intravenous (IV) antiviral agents effectively reduce CMV viral load and achieve viral clearance. Studies comparing oral and IV anti-CMV preemptive treatment in ASCT [...] |
A Rare and Complex Case of Multifactorial Thrombotic Microangiopathy in A Kidney Transplant Recipient: Interplay Between Antibody Mediated Rejection, Tacrolimus Toxicity, Cytomegalovirus Disease and BNT162b2mRNA VaccineAbstract Thrombotic microangiopathy (TMA) in kidney transplant recipients is uncommon and difficult to manage, often with poor graft outcomes [1]. This is a complex and interesting case of an older, highly sensitised kidney transplant recipient who presented with de novo post-transplant TMA in the setting of antibody mediated rejection (ABMR), with other drivers [...] |
Lung Transplantation for COVID-19 Related Lung Disease: A Follow-Up Study of Outcomes from a Medium-Size Lung Transplant Programdby
Domingo Franco-Palacios
,
Lisa Allenspach
,
Lisa Stagner
,
Kelly Bryce
,
Jane Simanovski
and
Hassan Nemeh
Abstract In the United States of America, COVID-19 acute respiratory distress syndrome (ARDS) and post-COVID pulmonary fibrosis (PCPF) are raising indications for lung transplant (LT). Another indication for LT is underlying fibrosis with SARS-CoV-2 induced interstitial lung disease exacerbation or rapid progressing fibrosis. Only a few centers have reported [...] |
BK Virus Infection and Its Management in Renal Transplantation: An Updateby
Uttayan Chakrabarti
,
Manish Chaturvedy
,
Nitin Kumar Bajpai
,
Jitendra Goswami
,
Rajesh Kumar Garsa
and
Rajesh Jhorawat
Abstract BK virus (BKV) is a common opportunistic pathogen in kidney transplant recipients and one of the most challenging causes of allograft dysfunction and loss. Although over-immunosuppression remains the primary risk factor for BKV infection after transplantation, male gender, older recipient age, prior rejection episodes, degree of human leukocyte antigen [...] |
Identification of Potential Predictive and Diagnostic Urinary Biomarkers for Acute Rejection in Renal Transplant Recipients: A Proteomics Studyby
Mohsen Nafar
,
Shiva Samavat
,
Nooshin Dalili
,
Shiva Kalantari
,
Leonard Foster
,
Kyung-Mee Moon
and
Somaye-Sadat Heidari
Abstract Acute rejection (AR) is one of the main predictors of long-term survival of allograft. The development of noninvasive diagnostic biomarkers of AR is an unmet need for the timely detection. This study aimed to identify novel detective biomarkers of AR by analyzing the urine proteome profile of transplant patients. Forty-two transplant patients including [...] |
Biomarkers in the Management of the Lung Transplant Allograft: A Focus on Donor-derived Cell-free DNAAbstract Advances in the use of molecular biomarkers to guide management of lung transplant recipients are emerging. One such biomarker, donor-derived cell-free DNA (dd-cfDNA), has the potential to alter traditional approaches of lung transplant management, including the detection of acute rejection or infection, surveillance monitoring strategies, risk stratifi [...] |
Kidney Transplantation in Nigeria: A Single Centre’s Early Surgical Experience and Outcomesby
Martin Igbokwe
,
Olalekan Olatise
,
Thelma Olatise
,
Sadiq Abu
,
Abayomi Aremu
,
Uzodinma Onwuasoanya
,
Ahmad Lawal
,
Ikechukwu Anosike
,
Adegboyega Faponle
,
Adam Ochigbo
,
Chukwunonso Epundu
,
Stephen Asaolu
,
Sani Alhassan
and
Rashad Hazem
Abstract With the rise in the population of patients with End-stage Renal Disease (ESRD) in Nigeria, there is an increased demand for Renal Replacement Therapy (RRT) including kidney transplantation (KT). We present our initial surgical experience and early outcomes with KT at a Nigerian transplant center over 2 years. A 2-year retrospective review of patients [...] |
Open Access Short Communication Surgical Tips for Improving Success Rate of Deep Anterior Lamellar Keratoplasty in Keratoconusby
Costanza Rossi
,
Vincenzo Scorcia
,
Massimiliano Borselli
,
Giuseppe Giannaccare
,
Rossella Spena
and
Andrea Lucisano
Abstract This article aims to provide some personal surgical tips to increase the success rate of deep anterior lamellar keratoplasty (DALK), a very advantageous yet complex procedure for treating keratoconus. The most troublesome surgical step is obtaining a successful pneumatic dissection of the deep stromal tissue, allowing the exposure of a deep cleavage [...] |
It is our pleasure to announce that LIDSEN has joined the ORCID community. ORCID (Open Researcher and Contributor ID), a global, not-for-profit organization, provides a free, unique, and persistent digital identifier (an ORCID iD), which can automatically link researchers to their own contributions, so as to disambiguate researchers from one another. Authors who publish with OBM Transplantation are greatly encouraged to register for a unique iD to ensure proper attribution.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Maurizio Salvadori from Careggi University Hospital, Italy, to join the Editorial Board of OBM Transplantation. Prof. Salvadori is a Professor, Professor, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. Prof. Salvadori has extensive experience in kidney transplantation, transplantation, clinical nephrology, chronic renal failure, immunology, infectious diseases, and antibody-mediated rejection. We are grateful to Prof. Salvadori for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Tatsuya Kin from University of Alberta, Canada, to join the Editorial Board of OBM Transplantation. Dr. Kin is the Director, Clinical Islet Laboratory, Department of Surgery, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada. Dr. Kin has extensive experience in islet isolation, islet transplantation, organ preservation, organ donation, transplantation, and diabetes. We are grateful to Dr. Kin for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Luca Brazzi from University of Turin, Italy, to join the Editorial Board of OBM Transplantation. Prof. Brazzi is a Professor, Chief, Director, Department of Surgical Science, University of Turin, University Hospital Città della Salute e della Scienza, Corso Dogliotti 14, 10126 Turin, Italy. Prof. Brazzi has extensive experience in anaesthesiology, transplant anaesthesiology, anaesthetics, and preservation of donor organs. We are grateful to Prof. Brazzi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Nidhi Sharma from Ohio State University, USA, to join the Editorial Board of OBM Transplantation. Dr. Sharma is from Division of Hematology, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH, USA. Dr. Sharma’s research interest is in the field of stem cell transplantation (autologous and allogenic), and graft vs host disease (GVHD). We are grateful to Dr. Sharma for the participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Marina Moguilevitch from Montefiore Medical Center, Albert Einstein College of Medicine, USA, to join the Editorial Board of OBM Transplantation. Prof. Moguilevitch is an Associate Professor of Clinical Anesthesiology, Director of Transplant Anesthesia Service, Divsion of Transplant Anesthesiolgy, Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA. She has extensive experience in anesthesiology, transplant anesthesiology, and liver transplantation. We are grateful to Prof. Moguilevitch for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Malcolm Voyce from Macquarie Law School, Macquarie University, Australia, to join the Editorial Board of OBM Transplantation. Prof. Voyce is a Professor of Law, Macquarie Law School, Macquarie University, NSW 2109 Australia. He has extensive experience in property law and succession concerning the privatisation of public property, geographical indications, intellectual property rights, social welfare, family farm inheritance and organ transplants, law and religion, and Buddhism and Islam. We are grateful to Prof. Voyce for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Maricar Malinis from Yale School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Malinis is an Associate Professor of Medicine and Surgery (Transplant), Medical Director, Transplant Infectious Diseases, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. She has extensive experience in aging, CMV, fungal infections, immunocompromised host and transplant infectious diseases. We are grateful to Dr. Malinis for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Paolo Muiesan from Queen Elizabeth & Birmingham Children's Hospitals, USA, to join the Editorial Board of OBM Transplantation. Professor Muiesan is the Professor of HPB Surgery & Liver Transplantation, Liver Unit, Queen Elizabeth & Birmingham Children's Hospitals, Mindelsonway, Birmingham B15 2TH, United Kingdom. He has extensive experience in adult and paediatric liver transplantation, hepatobiliary surgery, liver tumors, general surgery, vascular surgery, laparoscopic liver surgery, liver resections for cholangiocarcinoma, parenchymal sparing central resections, ALPPS and ex-vivo resections. We are grateful to Prof. Muiesan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mohammed Moghadasian from University of Manitoba, Canada, to join the Editorial Board of OBM Transplantation. Professor Moghadasian is the Professor of Nutrition, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. He has extensive experience in diet, lipoprotein metabolism, coronary artery disease, diet-drug interaction, and diets and transplantation. We are grateful to Prof. Moghadasian for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Esma S. Yolcu to join the Editorial Board of OBM Transplantation. Dr. Yolcu is an Associate Professor at Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, USA. Her main research interests are immunotherapy, ProtEx™ technology, gene therapy, immunomodulation, tolerance, host-versus-graft (HVG) and graft-versus-host (GVH). We are grateful to Dr. Yolcu for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We sincerely welcome Professor Haval Shirwan from University of Louisville, USA, to lead the journal OBM Transplantation as the Editor-in-Chief. Professor Shirwan is an internationally renowned immunologist recognized for his pioneering approach to generate novel immunological ligands and their transient and positional display on biologic and nonbiologic surfaces for localized immunomodulation with applications to transplantation, autoimmunity, and cancer immunoprevention and immunotherapy. We appreciate Professor Haval Shirwan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mureo Kasahara from National Center for Child Health and Development, Tokyo, Japan, to join the Editorial Board of OBM Transplantation. Prof. Kasahara is the Director, Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan. He has extensive clinical experience in the kidney transplantation, liver transplantation, liver surgery, pediatric organ transplantation, liver diseases and immunology, transplant immunology, transplant medicine and transplant surgery. We are grateful to Prof. Kasahara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Associate Professor Chirag S. Desai to join the Editorial Board of OBM Transplantation. Dr. Desai is an Associate Professor at Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. His main research interests are liver transplantation, intestinal and multivisceral transplantation, liver and pancreatobiliary disorders, chronic pancreatitis and autologous islet cell transplantation. We are grateful to Dr. Desai for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Sherif Beniameen Mossad to join the Editorial Board of OBM Transplantation. Dr. Mossad is a staff physician in the Department of Infectious Disease, Respiratory Institute, and Transplantation Center, Cleveland Clinic, Ohio, USA. His main research interests are transplant infectious disease, influenza and common cold. We are grateful to Dr. Mossad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor René Adam to join the Editorial Board of OBM Transplantation. Dr. Adam is a Professor and Head Department of Hepatobiliary Surgery, Cancer and Transplantation, Centre Hepato-Biliaire, Hopital Paul-Brousse, 94804 Villejuif, France. His main research interests are surgery of the liver, biliary tract and pancreas, hepatic transplantation, liver diseases, hepatocellular carcinoma, hepatobiliary surgery, and liver transplantation. We are grateful to Dr. Adam for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Yasuhiko Sugawara to join the Editorial Board of OBM Transplantation. Dr. Sugawara is a Professor at Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Japan. His main research interests are hepatobiliary surgery and liver transplantation. We are grateful to Dr. Sugawara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Taizo Hibi to join the Editorial Board of OBM Transplantation. Dr. Hibi is a Professor and Chairman at the Department of Transplantation and Pediatric Surgery, Kumamoto University Graduate School of Medical Sciences, Japan. His main research interests are surgical oncology, hepatobiliary and pancreatic surgery, living donor liver transplantation, intestinal/multivisceral transplantation, and transplant/tumor immunology. We are grateful to Dr. Hibi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kåre I. Birkeland to join the Editorial Board of OBM Transplantation. Dr. Birkeland is a Professor at the Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway. His main research interests are diabetes, clinical and mechanistic studies; insulin resistance and metabolic syndrome; laboratory endocrinology; and islet and pancreas transplantation. We are grateful to Dr. Birkeland for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Waldo Concepcion from Stanford University, USA, to join the Editorial Board of OBM Transplantation. Professor Concepcion is the Chief of Clinical Transplantation, Stanford University Medical Center and the Chief of Pediatric Kidney Transplantation, Lucille Packard Children's Hospital. He has extensive clinical and research experience in liver and kidney transplantation and has published over 104 peer reviewed articles. We are grateful to Professor Concepcion for his participation and support.
OBM Transplantation Welcomes the Founding Editor-in-Chief — Professor Pål Dag Line
We welcome Professor Pål Dag Line, from Oslo University, Norway, to lead the journal OBM Transplantation as the founding Editor-in-Chief. Professor Line is also the Head of Department of Organ Transplantation at Oslo University Hospital. He is an internationally recognized expert specializing in transplant surgery, vascular surgery, and HPB surgery, etc. He has published over 118 peer reviewed articles in international professional journals. We are very grateful to Professor Line for his participation and great support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Milagros D. Samaniego-Picota from University of Michigan, USA, to join the Editorial Board of OBM Transplantation. Professor Samaniego-Picota's clinical and research interests focus on experimental and clinical antibody-mediated rejection, desensitization protocols, and the care of highly sensitized patients. We are grateful to Professor Samaniego-Picota for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Haley Hoy from the University of Alabama in Huntsville, USA, to join the Editorial Board of OBM Transplantation. Dr. Hoy has extensive clinical and research experience in Pulmonary, Nursing and Transplantation, Quality of life, Web-based Mobile Technology, etc. We are grateful to Dr. Hoy for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kamyar Afshar from UCSD Pulmonary, Critical Care and Sleep Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Afshar is a board-certified pulmonologist who specializes in complex lung diseases and lung transplantation. He is also a member of numerous professional organizations, including the International Society of Heart and Lung Transplant, the American Thoracic Society, the American College of Chest Physicians, and the Society of Critical Care Medicine, etc. We are grateful to Dr. Afshar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Muhammad Mujtaba from the University of Texas Medical Branch Galveston, USA, to join the Editorial Board of OBM Transplantation. Dr. Mujtaba has extensive clinical and research experience in kidney and pancreas transplantation including high risk transplant, immunomodulation/desensitization protocols, early steroid withdrawal, antibody mediated rejection, post-transplant antibody monitoring, and BK virus management post-transplant, etc. We are grateful to Dr. Mujtaba for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Wasim A. Dar from the University of Texas at Houston, USA, to join the Editorial Board of OBM Transplantation. Dr. Dar specializes in abdominal solid organ transplantation, laparoscopic donor nephrectomy for living donor kidney transplantation, and hepatobiliary surgery for benign and malignant disease. His research interests include basic-science and clinical research in the study of organ transplant immunology and clinical outcomes related to organ transplant. We are grateful to Dr. Dar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Jeffrey B. Halldorson from the University of California at San Diego, USA, to join the Editorial Board of OBM Transplantation. Dr. Halldorson is an Associate Professor of Surgery specializing in all aspects of Liver, Kidney and Pancreas transplantation as well as Liver and Hepatobiliary surgery and general surgery as applied to the transplant patient. Dr. Halldorson has authored numerous manuscripts in peer reviewed journals regarding his research in improving outcomes of donor organs and recipients by optimizing the matching process. We are grateful to Dr. Halldorson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Malek G. Massad from University of Illinois, USA, to join the Editorial Board of OBM Transplantation. Professor Massad is the Chief of the University of Illinois Hospital Cardiothoracic Surgery team. His team provides an innovative approach to cardiac and thoracic diseases. We are grateful to Professor Massad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Simon C. Robson to join the Editorial Board of OBM Transplantation. Professor Robson is a physician scientist in the Liver Center and Transplant Institute at the Beth Israel Deaconess Medical Center, Harvard University in Boston, where he served as Chief of Gastroenterology and Hepatology, as well as Director of Liver Research. We are grateful to Professor Robson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Raman Venkataramanan from University of Pittsburgh, USA, to join the Editorial Board of OBM Transplantation. Professor Venkataramanan is the Director of the Clinical Pharmacokinetics Laboratory at University of Pittsburgh. His research focuses on the functional capacity of transplanted organs and optimization of immunosuppressive drug therapy in organ transplant patients. Professor Venkataramanan has presented more than 175 lectures/seminars at national/international meetings and published over 350 research articles. We are grateful to Professor Venkataramanan for his participation and support.
OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
Review
by Shefali Mody et al.
OBM Transplantation 2024
Published: 23 November 2023
Review
by Mostafa Mohammed et al.
OBM Transplantation 2024
Published: 06 November 2023
Review
by Brandon Menachem et al.
OBM Transplantation 2024
Published: 21 November 2023
Original Research
by Francesco Peracchi et al.
OBM Transplantation 2024
Published: 01 December 2023
Original Research
by Sarah Willi et al.
OBM Transplantation 2024
Published: 04 February 2024
TOP